IWMvsXBI
iShares Russell 2000 ETF against SPDR S&P Biotech ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IWM | XBI | |
|---|---|---|
| Expense ratio | 0.19% | 0.35% |
| Assets | $79.3B | $10.3B |
| Net flow, 1 month | +$2.3B | −$567M |
| Net flow, 1 year | −$1.2B | +$935M |
| Return, YTD | +14.3% | +23.8% |
| Return, 1 year | +14.0% | +45.6% |
| Avg daily volume | 24.8M | 8.9M |
| Holdings | 1941 | 135 |
| Listed | May 22, 2000 | Jan 31, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS